This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (49)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Lois E. Donovan, MD, FRCPC; Bernard Corenblum, MD, FRCPC

Arch Intern Med. 1995;155(2):181-183.

Abstract
Background
The wide availability of computed tomography and magnetic resonance imaging has resulted in the discovery of unsuspected endocrinologically silent pituitary masses (incidentalomas). Because the natural history of this entity is not known, the approach to the pituitary incidentaloma has not been established.

Objective
To determine the natural history of untreated pituitary incidentaloma, recognizing that this includes lesions of various causes.

Methods
Thirty-one adults with incidentalomas were prospectively followed up conservatively for a mean of 6.4 years (range, 3 to 11 years). Clinical and biochemical assessment, computed tomography or magnetic resonance imaging of the pituitary, and visual field testing by Goldmann perimetry at baseline, 6 months, and yearly thereafter were the outcomes assessed.

Results
Only patients with pituitary incidentalomas greater than 10 mm in greatest diameter developed tumor enlargement or complications. Three patients developed asymptomatic tumor enlargement. In four patients, masses decreased in size. Only two patients developed complications. One required subsequent surgery. The only permanent impairment was panhypopituitarism following surgery in this patient.

Conclusions
Patients with pituitary incidentalomas of unknown causes usually follow a benign course for at least 6 years after discovery. Neurosurgical intervention is not initially required in the management of pituitary incidentalomas, particularly those less than 10 mm, as long as clinical observation can be continued.

(Arch Intern Med. 1995;155:181-183)

Author Affiliations
From the Division of Endocrinology and Metabolism, University of Calgary Health Sciences Centre, Alberta.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predicting Recurrence of Nonfunctioning Pituitary Adenomas
Noh et al.
J. Clin. Endocrinol. Metab. 2009;94:4406-4413.
ABSTRACT | FULL TEXT  

Evaluation and management of pituitary incidentalomas
SERHAL et al.
Cleveland Clinic Journal of Medicine 2008;75:793-801.
ABSTRACT | FULL TEXT  

Treatment and Follow-Up of Clinically Nonfunctioning Pituitary Macroadenomas
Dekkers et al.
J. Clin. Endocrinol. Metab. 2008;93:3717-3726.
ABSTRACT | FULL TEXT  

Growth modelling of non-functioning pituitary adenomas in patients referred for surgery
Honegger et al.
Eur J Endocrinol 2008;158:287-294.
ABSTRACT | FULL TEXT  

The natural course of non-functioning pituitary macroadenomas
Dekkers et al.
Eur J Endocrinol 2007;156:217-224.
ABSTRACT | FULL TEXT  

Normal Pituitary Hypertrophy as a Frequent Cause of Pituitary Incidentaloma: A Follow-Up Study
Chanson et al.
J. Clin. Endocrinol. Metab. 2001;86:3009-3015.
ABSTRACT | FULL TEXT  

Studying Symptoms: Sampling and Measurement Issues
Kroenke
ANN INTERN MED 2001;134:844-853.
ABSTRACT | FULL TEXT  

Management of Incidental Pituitary Microadenomas: A Cost-Effectiveness Analysis
King et al.
J. Clin. Endocrinol. Metab. 1997;82:3625-3632.
ABSTRACT | FULL TEXT  

THE NATURAL HISTORY OF PITUITARY INCIDENTALOMAS
JWatch General 1995;1995:6-6.
FULL TEXT